BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1250378)

  • 1. Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours.
    Likhite VV
    Nature; 1976 Feb; 259(5542):397-9. PubMed ID: 1250378
    [No Abstract]   [Full Text] [Related]  

  • 2. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW; Cruickshank N; Fowler EF
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 8. The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.
    Woodruff M; Dunbar N; Ghaffar A
    Proc R Soc Lond B Biol Sci; 1973 Aug; 184(1074):97-102. PubMed ID: 4147951
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitumor effect of Corynebacterium parvum].
    Mazurek C; Chalvet H; Biozzi G; Stiffel C
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: The effect of Bacille Calmette-GuĂ©rin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delayed rejection of tumors formed from the administration of tumor cells mixed with killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Int J Cancer; 1973 Nov; 12(3):699-704. PubMed ID: 4524799
    [No Abstract]   [Full Text] [Related]  

  • 16. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV
    Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
    [No Abstract]   [Full Text] [Related]  

  • 17. Active experimental inhibition of cancer by corynebacterium parvum.
    Wrba H; Dutter A
    Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
    Moroson H; Stowe S; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.